← Open Payments lookup

KATHLYN ROWEN: Open Payments

NPI 1649300179 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$714 in 32 payments from 9 companies in 2025. Trend: 2023 $621 · 2024 $578 · 2025 $714

Food & beverage: $714
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.4$199
Bausch Health US, LLC13$174
Alkermes, Inc.3$84
Otsuka America Pharmaceutical, Inc.3$62
Takeda Pharmaceuticals U.S.A., Inc.2$56
ABBVIE INC.2$51
Axsome Therapeutics, Inc.2$39
Vanda Pharmaceuticals Inc.2$32
Janssen Pharmaceuticals, Inc1$17

Products named: INGREZZA, APLENZIN, LYBALVI, REXULTI, TRINTELLIX, VRAYLAR, Auvelity, FANAPT.

Industry payments across DE — which companies pay providers there.